glp-1 news today 2025 november As Drugs Go Mainstream, This Expert Says Health is More than a Number on a Scale GLP-1 Pipeline Update: November 2025

Brands are listed as examples only

Newsletter Signup - Under Article / In Page "*" indicates required fields In 2020, Novo Nordisks Canadian patent for semaglutide, the active ingredient in its blockbuster GLP-1 drugs Ozempic and Wegovy, quietly expired

Mitochondrial dysfunction: Roles in skeletal muscle atrophy

10.1021/bi200605h [DOI] [PubMed] [Google Scholar] 12.Abbott CA, McCaughan GW, Gorrell MD

Conversely, non-surgical treatments have gained popularity for their minimally invasive nature and quicker recovery periods

Patients on maintenance doses retained 70 to 85% of their peak weight loss at two years, compared to 40 to 60% retention for those who stopped completely but implemented lifestyle changes, and less than 30% for those who stopped without significant lifestyle modification